This statement has been organized by Rhia Ventures, a social impact organization developing a vibrant market for reproductive and maternal health that supports equitable outcomes for women and other birthing people in the US. Since 2019, Rhia has worked closely with institutional investors to advance stronger corporate policies with respect to reproductive and maternal health care.

For more information, contact [email protected]

The purpose of this statement is to convey to corporate leaders that ongoing efforts to restrict access to abortion and other forms of reproductive health care negatively impact employee health and wellbeing, with long-term repercussions to communities, businesses, and the economy as a whole. Investors have responded positively to this message in numerous shareholder proposals filed in recent proxy seasons. This statement provides another venue to express concern to the corporate community as a whole.

The statement can be referenced in communications to policymakers, companies, the media, and others.

For example: “Many investors have signed on to a statement expressing raised expectations for corporate policies and practices regarding reproductive and maternal health care in the post-Roe era.”

or: “Asset owners and managers collectively responsible for $__ in AUM have endorsed a statement encouraging companies to ensure access to comprehensive reproductive health care services, respect and protect the personal health information of patients and individuals, and provide family-friendly benefits.”

The statement should not be used to imply that the signatories have (1) endorsed any specific piece of legislation or other public policy initiatives such as ballot measures or executive orders, or (2) endorsed or supported any specific shareholder proposal.

We will accept endorsements on a rolling basis.